✦ LIBER ✦
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide
✍ Scribed by Elizabeth R. Gerstner; April F. Eichler; Scott R. Plotkin; Jan Drappatz; Colin L. Doyle; Lei Xu; Dan G. Duda; Patrick Y. Wen; Rakesh K. Jain; Tracy T. Batchelor
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 244 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.